Increased investment in pharmaceutical research and development and rising demand for biological products are driving market growth.
In the pharmaceutical industry, there is active investment in research and development, with advanced companies allocating an average of 15% of their sales to R&D. Many pharmaceutical companies are increasing their R&D budgets to aid in the development of new drugs and therapies. In 2022, major pharmaceutical companies such as Roche, Pfizer, Merck, and Bristol-Myers Squibb are expected to allocate about one-fifth of their annual sales to R&D expenses. This research report investigates the CMO market for sterile injectable drugs, providing forecasts from 2024 to 2034 categorized by molecular type, type, application, container type, route of administration, and service. It also offers information on related companies. [Contents (excerpt)] 1. Report Overview 2. Market Overview 3. Market Analysis (by molecular type, type, application, container type, route of administration, service) 4. Market Analysis: By Region (North America, Europe, Asia-Pacific, Latin America, MEA) 5. Company Profiles Report details: https://www.dri.co.jp/auto/report/visiongain/231025-contract-manufacturing.html
Inquire About This Product
basic information
**Summary (Excerpt)** Publisher: Visiongain Publication Date: October 2023 Number of Pages: 428 Language: English *Our data resources are authorized distributors of Visiongain.*
Price range
Delivery Time
P2
Applications/Examples of results
*For more details, please visit our company website.*
Company information
Data Resource Co., Ltd. provides valuable information and analytical data for business strategy planning, including the latest market information on telecommunications, computers, electronics, energy, and automotive-related sectors worldwide, as well as competitor strategies, the development of new technologies and services, regulations, and intellectual property.